Publication of a Transparency Notification Received from Tolefi SA (Article 14§1 of the Law of 2 May 2007)
Regulatory News:
Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a transparency notification dated July 24, 2026, from Tolefi SA and related persons indicating that they have jointly crossed passively below the 10% threshold, holding 6,568,978 shares, or 8.77% of the voting rights of the Company as of July 16, 2026.
Content of the Notification:
Reason of the notification:
